GlaxoSmithKline reported 1.4B in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Alcon AG ALC:SW 151M 67M
Amgen AMGN:US $ 464M 1182M
AstraZeneca AZN:LN 550M 1011M
Bayer BAYN:GR € -2335M 4424M
Biogen BIIB:US $ 448.5M 38.3M
Bristol Myers Squibb BMY:US $ 1055M 966M
Eli Lilly And LLY:US $ 1390.2M 34.9M
Fresenius FRE:GR € 471M 36M
Fresenius Medical Care FME:GR € 219M 30M
Galapagos GLPG:NA € -64.33M 73.69M
Genmab GEN:DC DK 306M 790M
Gilead Sciences GILD:US $ 1522M 207M
GlaxoSmithKline GSK:LN 1395M 322M
Glaxosmithkline GSK:US $ 1395M 322M
GRIFOLS GRF:SM € 136.88M 6.94M
H. Lundbeck A/S LUN:DC 378M 243M
Hikma Pharmaceutical HIK:LN 248M 29M
Lonza Group LONN:SW 319M 73M
Merck MRK:GR € 745M 2M
Merk MRK:US $ 1545M 1634M
Novartis NOVN:VX SF 2896M 837M
Orion ORNBV:FH € 56M 3.5M
Pfizer PFE:US $ 5564M 686M
Philips PHIA:NA € 151M 113M
Recordati REC:IM € 117.21M 27.34M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M